Cargando…

Effects of Exogenous Hormones and Reproductive Factors on Female Melanoma: A Meta-Analysis

Epidemiological findings on the effects of hormones on melanoma risk have been inconsistent. We therefore conducted a meta-analysis to examine the relationship between exogenous hormonal and reproductive factors and the risk of melanoma in women. We performed a search of PubMed, Web of Science, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Qian, Sun, Hongyan, Cong, Lele, Zheng, Yang, Wu, Nan, Cong, Xianling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605627/
https://www.ncbi.nlm.nih.gov/pubmed/33149695
http://dx.doi.org/10.2147/CLEP.S273566
_version_ 1783604341395947520
author Sun, Qian
Sun, Hongyan
Cong, Lele
Zheng, Yang
Wu, Nan
Cong, Xianling
author_facet Sun, Qian
Sun, Hongyan
Cong, Lele
Zheng, Yang
Wu, Nan
Cong, Xianling
author_sort Sun, Qian
collection PubMed
description Epidemiological findings on the effects of hormones on melanoma risk have been inconsistent. We therefore conducted a meta-analysis to examine the relationship between exogenous hormonal and reproductive factors and the risk of melanoma in women. We performed a search of PubMed, Web of Science, and the China National Knowledge Infrastructure (CNKI) database through April 2020 for relevant studies. Based on heterogeneity, we performed the meta-analysis of the risk estimates using either fixed effect or random effect models. We identified 38 studies that met the analytical criteria, involving 3,571,910 participants. The results showed that long-term use of oral contraceptives (OC) may increase the risk of melanoma in women (≥5 years [pooled RR=1.18; 95% CI: 1.07–1.31; I(2)=0%] and ≥10 years [pooled RR=1.25; 95% CI: 1.06–1.48; I(2)=0%]). Women who first used OC 15–19 years previously were more likely to develop melanoma (pooled RR=1.52; 95% CI: 1.03–2.24; I(2)=0%), while the years since the last use and the age at first use were not associated with the development of melanoma in women. Hormone replacement therapy (HRT) increased the incidence of melanoma in women (pooled RR=1.12, 95% CI: 1.02–1.24; I(2)=50%) and was especially associated with an increased risk of superficial spreading melanoma (SSM) (pooled RR=1.26; 95% CI: 1.17–1.37; I(2)=0%), and estrogen and estradiol may be the main active agents that contribute to the increased risk of melanoma, but these results may be due to a combination of sun exposure factors. With regard to reproductive factors, decreased parity and being aged ≥20 years at first birth may be associated with an increased risk of melanoma in females, while menopausal status and age at menarche are not associated with the incidence of melanoma in females. Further large-scale prospective studies are necessary to reveal new pathophysiological mechanisms and new therapeutic targets for cutaneous melanoma.
format Online
Article
Text
id pubmed-7605627
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-76056272020-11-03 Effects of Exogenous Hormones and Reproductive Factors on Female Melanoma: A Meta-Analysis Sun, Qian Sun, Hongyan Cong, Lele Zheng, Yang Wu, Nan Cong, Xianling Clin Epidemiol Review Epidemiological findings on the effects of hormones on melanoma risk have been inconsistent. We therefore conducted a meta-analysis to examine the relationship between exogenous hormonal and reproductive factors and the risk of melanoma in women. We performed a search of PubMed, Web of Science, and the China National Knowledge Infrastructure (CNKI) database through April 2020 for relevant studies. Based on heterogeneity, we performed the meta-analysis of the risk estimates using either fixed effect or random effect models. We identified 38 studies that met the analytical criteria, involving 3,571,910 participants. The results showed that long-term use of oral contraceptives (OC) may increase the risk of melanoma in women (≥5 years [pooled RR=1.18; 95% CI: 1.07–1.31; I(2)=0%] and ≥10 years [pooled RR=1.25; 95% CI: 1.06–1.48; I(2)=0%]). Women who first used OC 15–19 years previously were more likely to develop melanoma (pooled RR=1.52; 95% CI: 1.03–2.24; I(2)=0%), while the years since the last use and the age at first use were not associated with the development of melanoma in women. Hormone replacement therapy (HRT) increased the incidence of melanoma in women (pooled RR=1.12, 95% CI: 1.02–1.24; I(2)=50%) and was especially associated with an increased risk of superficial spreading melanoma (SSM) (pooled RR=1.26; 95% CI: 1.17–1.37; I(2)=0%), and estrogen and estradiol may be the main active agents that contribute to the increased risk of melanoma, but these results may be due to a combination of sun exposure factors. With regard to reproductive factors, decreased parity and being aged ≥20 years at first birth may be associated with an increased risk of melanoma in females, while menopausal status and age at menarche are not associated with the incidence of melanoma in females. Further large-scale prospective studies are necessary to reveal new pathophysiological mechanisms and new therapeutic targets for cutaneous melanoma. Dove 2020-10-29 /pmc/articles/PMC7605627/ /pubmed/33149695 http://dx.doi.org/10.2147/CLEP.S273566 Text en © 2020 Sun et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Sun, Qian
Sun, Hongyan
Cong, Lele
Zheng, Yang
Wu, Nan
Cong, Xianling
Effects of Exogenous Hormones and Reproductive Factors on Female Melanoma: A Meta-Analysis
title Effects of Exogenous Hormones and Reproductive Factors on Female Melanoma: A Meta-Analysis
title_full Effects of Exogenous Hormones and Reproductive Factors on Female Melanoma: A Meta-Analysis
title_fullStr Effects of Exogenous Hormones and Reproductive Factors on Female Melanoma: A Meta-Analysis
title_full_unstemmed Effects of Exogenous Hormones and Reproductive Factors on Female Melanoma: A Meta-Analysis
title_short Effects of Exogenous Hormones and Reproductive Factors on Female Melanoma: A Meta-Analysis
title_sort effects of exogenous hormones and reproductive factors on female melanoma: a meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605627/
https://www.ncbi.nlm.nih.gov/pubmed/33149695
http://dx.doi.org/10.2147/CLEP.S273566
work_keys_str_mv AT sunqian effectsofexogenoushormonesandreproductivefactorsonfemalemelanomaametaanalysis
AT sunhongyan effectsofexogenoushormonesandreproductivefactorsonfemalemelanomaametaanalysis
AT conglele effectsofexogenoushormonesandreproductivefactorsonfemalemelanomaametaanalysis
AT zhengyang effectsofexogenoushormonesandreproductivefactorsonfemalemelanomaametaanalysis
AT wunan effectsofexogenoushormonesandreproductivefactorsonfemalemelanomaametaanalysis
AT congxianling effectsofexogenoushormonesandreproductivefactorsonfemalemelanomaametaanalysis